What is Laxmi Dental Ltd's market cap?

Laxmi Dental Ltd (LAXMIDENTL) has a market capitalization of ₹1,151 Cr.

What sector is LAXMIDENTL in?

Laxmi Dental Ltd operates in the Healthcare — Equipment & Devices sector.

What is LAXMIDENTL's return on equity?

Laxmi Dental Ltd has a return on equity (ROE) of 10.1%.

Loading company...

Analyzing...

Laxmi Dental Ltd (LAXMIDENTL) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Laxmi Dental Ltd

LAXMIDENTL|BSE: 544339

Healthcare — Equipment & DevicesHealthcare & Life Scienceswww.laxmidentallimited.com

₹230.00

+₹4.00 (+1.77%)|MCap ₹1,151 Cr

As of 16 Jun 2026 (End of Day)

52W Low ₹155.8852W High ₹509.95

Laxmi Dental Ltd manufactures and supplies dental equipment, instruments, and oral healthcare products. The company serves dental clinics, hospitals, and educational institutions, combining innovation

Secular Currents

Theme Connections

Healthcare Access PLI Manufacturing

Intelligence Profile

TSF Score

49/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

5Clean

Trust Score

X-Ray

Concerns

No significant concerns identified

Watch

Nothing flagged for monitoring

Strengths

🟢Low leverage (D/E: 0.00x)Business

The Numbers · Key Metrics

ROE

10.1%

Debt/Equity

0.00x

₹1,061 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Equipment & DevicesProduct Sales ModelModel:Revenue = Units Sold × Average Selling Price + Service & AMC Revenue

Key Insight

“Operates in Healthcare — Equipment & Devices.”

The Revenue Story

₹239 Cr revenue.

Total Income₹242 Cr

Revenue₹239 Cr(98.6% of Total Income)

Other Income₹3 Cr(1.4% of Total Income)

The Cost Story

COGS 23.9%, employees 35.9%.

Employee₹86 Cr(32.6%)

Cogs₹57 Cr(21.8%)

Other Expenses₹54 Cr(20.6%)

EBITDA₹45 Cr(17.2%)

Depreciation₹15 Cr(5.7%)

Finance Costs₹5 Cr(2.1%)

0.2%EBITDA Margin

Employee

32.6%

Cogs

21.8%

Other Expenses

20.6%

EBITDA

17.2%

Depreciation

5.7%

Finance Costs

2.1%

Key Metrics

ROE

10.1%

vs median 12.3%

ROCE

10.9%

vs median 15.3%

Net Margin

8.5%

vs median 8.5%

EBITDA Margin

15.4%

vs median 14.9%

Debt To Equity

0.00x

vs median 0.10x

Forward View · Management Guidance

GUIDANCEQ2FY26— 3High Impact

“we can still do it between 13 to 15% [PAT margins] even at the current scenario”

GUIDANCEQ2FY26— 3High Impact

“20% is at least the target, our first target for benchmark to reach in terms of the EBITDA. In fact, margin for this survey, we have already said 13% to 15%.”

FINANCIALQ2FY26— 3High Impact

“we have been able to improve our margins from what we were last quarter to this quarter, in this bin...from 6.8% to 15.8%.”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Equipment & Devices

KPI	Company	Sector Median
ROE	10.1%▼	12.3%
ROCE	10.9%▼	15.3%
Net Margin	8.5%▲	8.5%
EBITDA Margin	15.4%▲	14.9%
Debt To Equity	0.00x▼	0.10x

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Low Impact

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹265 Cr

PBT₹24 Cr

EPS₹4.22

(₹ Cr)	TTM	FY2025
Revenue	₹265 Cr +10.6%	₹239 Cr
Other Income	₹8 Cr +134.2%	₹3 Cr
Total Income	₹272 Cr +12.4%	₹242 Cr
COGS	₹73 Cr +28.0%	₹57 Cr
	₹243 Cr +11.8%	₹218 Cr
Profit Before Tax	₹24 Cr -25.2%	₹32 Cr
Exceptional Items	(₹5 Cr) ↓ Decline	₹7 Cr
	₹4 Cr -30.7%	₹6 Cr
Net Profit	₹23 Cr -27.4%	₹32 Cr
Profit (Owners)	₹23 Cr -27.0%	₹32 Cr
Minority Interest	(₹0.09 Cr) ↓ Decline	₹0.06 Cr
Other Comprehensive Income	(₹0.40 Cr) +25.1%	(₹0.53 Cr)
EPS	₹4.22	₹5.78
Diluted Shares	₹5 Cr	₹5 Cr
Profit Or Loss Of Associates	₹4 Cr -47.4%	₹7 Cr
Profit Loss From Discontinued Operations After Tax	₹0.00 Cr +100.0%	(₹0.71 Cr)